The objective of this study was to test the reliability and validity of the Turkish version of the Functional Living Index-Cancer in Turkey. The English version of the Functional Living Index-Cancer was translated into Turkish following the standard translation methodology. The questionnaire was administered to 110 cancer patients who had been receiving chemotherapy. Internal consistency reliability was in the acceptable range for this instrument. Among cancer patients, the Cronbach alpha reliability for the total scale was .88, and subscale alpha coefficients ranged from .60 to .83, which is similar to the alpha of .79 observed in the Functional Living Index-Cancer, English version. The results of the principle components analysis and varimax rotation resulted in 5-factor structure: physical functioning, psychological functioning, current well-being, social functioning, and gastrointestinal symptoms. The results of this study suggest that the Turkish version of the Functional Living Index-Cancer is a reliable and valid supplementary measure of the quality of life in cancer patients in Turkey, and it can be used in clinical trials and studies of outcome research in oncology.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/01.NCC.0000305684.51884.1f | DOI Listing |
Knee Surg Relat Res
January 2025
IU Health Physicians Orthopedics & Sports Medicine, 1801 N Senate Ave, Indianapolis, IN, 46202, USA.
Background: There are no studies that compare the outcomes and complications of single-versus two-stage revision anterior cruciate ligament reconstruction (ACLR) after primary ACLR failure. This purpose of this study is to examine clinical and functional outcomes and complications associated with single and two-stage revision ACLR after primary ACLR failure.
Methods: All patients who underwent single or two-stage revision ACLR after primary ACLR failure between 2012 and 2021 with a minimum of a 2 year follow-up were included.
BMC Geriatr
January 2025
Department of Pharmacy, Faculty of Pharmacy, Musashino University, 1-1-20 Shinmachi Nishitokyo-Shi, Tokyo, 202-8585, Japan.
Background: Edaravone is marketed in nine countries, although only Japan has approved edaravone for improvement of neurological symptom, disability of activities of daily living (ADL), and functional disability associated with acute stroke. This study aimed to elucidate the association of edaravone use with ADL using real-world data of older patients with atherothrombotic stroke.
Methods: This retrospective observational research using the Medical Data Vision database in Japan included patients aged 65 years and older who had acute ischemic stroke of the atherothrombotic subtype.
Sci Rep
January 2025
Department of Biological Sciences, California State University Los Angeles, 5151 State University Dr, Los Angeles, CA, 90032, USA.
The moss Syntrichia caninervis Mitt. is distributed throughout drylands globally, and often anchors ecologically significant communities known as biological soil crusts (biocrusts). The species occupies a variety of dryland habitats with varying levels of drought and temperature stress, suggesting the potential for ecological specialization within S.
View Article and Find Full Text PDFJMIR Cancer
January 2025
Department of Health and Kinesiology, University of Utah, Salt Lake City, UT, United States.
Background: Exercise can attenuate the deleterious combined effects of cancer treatment and aging among older adults with cancer, yet exercise participation is low. Telehealth exercise may improve exercise engagement by decreasing time and transportation barriers; however, the utility of telehealth exercise among older adults with cancer is not well established.
Objective: We aimed to evaluate the preliminary effectiveness of a one-on-one, supervised telehealth exercise program on physical function, muscular endurance, balance, and flexibility among older adults with cancer.
Int J Geriatr Psychiatry
January 2025
Department of Neurology, Tianjin Huanhu Hospital, Tianjin, China.
Background: Apolipoprotein E (ApoE) ε4 genotype is a well-known risk factor for Alzheimer's disease (AD). However, its effect on predicting cognitive decline in individuals without dementia and its association with age are unclear.
Objective: To investigate the relationship between ApoE polymorphism and risk of cognitive decline and dementia incidence in the elderly without dementia.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!